Results of radiation therapy for uterine cervical cancer using high dose rate remote after loading system

Yoshihiro Ogawa, Kenji Nemoto, Yoshihisa Kakuto, Hisanori Ariga, Haruo Matsushita, Ken Takeda, Chiaki Takahashi, Britton Gallardo, Keith Richard, Yoshihiro Takai, Shogo Yamada

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

In Japan, radiotherapy with high dose rate remote after loading system (HDR-RALS) for intracavitary brachytherapy is the standard treatment for more than 30 years. This report showed the usefulness of HDR-RALS for uterine cervical cancer. From 1980 through 1999, 442 patients with uterine cervical cancers (stage I: 66, stage II: 161, stage III: 165, stage IV: 50) were treated. Radiotherapy was performed both external teletherapy and HDR-RALS. Overall survival rate at 5 years was 60.2%. The 5-year actuarial incidence of all complications was 16.4%. The 5-year actuarial incidence of all complications in cases treated with the sum doses of whole pelvic irradiation (without central shield) and RALS up to 49 Gy, 50 to 59 Gy or larger doses were 7.5%, 11.0% and 25.2%, respectively. Radiation therapy using HDR-RALS was very effective. While the dose of whole pelvic irradiation was increased, the actuarial incidence of all complications was increased.

Original languageEnglish
Pages (from-to)229-238
Number of pages10
JournalTohoku Journal of Experimental Medicine
Volume199
Issue number4
DOIs
Publication statusPublished - 2003 Apr 1

Keywords

  • Brachytherapy
  • RALS
  • Radiotherapy
  • Uterine cervical cancer

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Results of radiation therapy for uterine cervical cancer using high dose rate remote after loading system'. Together they form a unique fingerprint.

Cite this